(butan-2-yl)[(3-phenoxyphenyl)methyl]amine hydrochloride, 95.0%, 2g

1-Bromo-2-ethoxy-5-fluorobenzene, 97.0%, 1g

4-AMINO-1-ETHYLPYRIDIN-2(1H)-ONE HCL, 95.0%, 10g

2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-one, 95%, 1g

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, 95.0%, 250mg

2-(3-hydroxyphenyl)-2-(phenylamino)acetonitrile, 95.0%, 2g

Acide nitrique, 40 %, pur, 5 l, emballage plastique.

4-(Bromomethyl)-2-chloropyridine hydrobromide, 95.0%, 250mg

6-bromo-1,4-dihydropteridin-4-one, 97%, 1g

4-tert-Butyl-3'-chloro-4'-fluorobenzophenone, 97.0%, 1g

4-Nitro-2(3H)-benzoxazolone, 97%, 1g

tert-butyl (1R,6S)-2,5-diazabicyclo[4.2.0]octane-2-carboxylate, 95, 250mg

2-((tert-Butoxycarbonyl)amino)-4-methoxy-4-oxobutanoic acid, 95.0%, 25g